| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Advertising > Pixel Advertising: Life after Death |
|
Digg It - Pixel Advertising: Life after Death
Pixel advertising continues to change as it evolves from a fad to a useful advertising tool According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product for targeted markets. What started with “The Million Dollar Home Page” by Alex Tew has co ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ntinued to morph into something else. Many have proclaimed that pixel advertising is dead. lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. They state that it was a fad and nothing more. Now it is definitely true that as soon as here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe people saw Alex Tew making an easy million dollars they all wanted to make some easy money d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro too. This created an instant wave of copycat sites trying to capitalize on the very trendy ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc concept of throwing up a pixel page and hoping people would respond to it just like they d easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi d with The Million Dollar Home Page. Of course, this was not to be the case. Alex Tew was nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically the inventor and with his fresh idea came the reward. But, it was not as easy for the fol and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ lowers and copycats. Many of these sites have come and gone with little to no fanfare. Wh ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi t is interesting to see now is that many people have taken this creative concept and adapte ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a d it to specific niches. For example, someone trying to raise funds for a worthy cause can dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod use a pixel site to help generate income in a unique and fun way. Other people have creat cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ed pixel sites that are targeted at specific markets where people with common interests can tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen advertise and find resources for the subject of their interest. Instead of pixel sites dyi t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ng out completely as some have suggested, new pixel sites are sprouting up daily capitalizi ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ng on this unique way of generating interest, income and advertising possibilities across a y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products broad spectrum of industries and ideas. Is pixel advertising dead? No, it is definitely n . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ot dead, but rather is adapting to the current landscape and carving out a unique way of dr elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip iving traffic and helping raise funds for different types of organizations around the globe tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Leveraging The Enterprise-Wide Knowledge Base Business in China #1 - Relaxing The Grip of Bureaucracy How to Advertise in a Magazine
|